Comparing Concussion Education Types

Comparison of Concussion Education Types

The purpose of this study is to determine if there are differences in knowledge, self-efficacy, and empathy surrounding concussions, as well as intent to report a concussion, after viewing concussion education (CrashCourse and Brain Fly-Through) in 2D versus in 3D.

In this randomized study, all participants will receive two types of concussion education (CrashCourse and Brain Fly-Through). Participants will be randomized to the 2D or 3D (Virtual Reality) group, and will experience both concussion educations in that modality (either 2D or 3D).

Study Overview

• Status: Recruiting
• Conditions: Brain Concussion; Knowledge, Attitudes, Practice
• Intervention / Treatment: Other: CrashCourse Concussion Education in Virtual Reality

Detailed Description

In this randomized study, all participants will receive two types of concussion education (CrashCourse and Brain Fly-Through). Participants will be randomized to the 2D or 3D (Virtual Reality) group, and will experience both concussion educations in that modality (either 2D or 3D).

During their in person study visit, participants will complete a brief ( ~5 minute) pre-survey before viewing the CrashCourse and Brain Fly-Through concussion educations. Participants will then be asked to complete a brief ( ~2 minute) survey to assess their knowledge, self-efficacy, and empathy surrounding concussions.

Two months later, participants will receive a brief ( ~5 minute) follow-up survey via email, assessing the same constructs.

• Study Type: Interventional
• Enrollment (Estimated): 40
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Daniel H Daneshvar, MD, PhD; Phone Number: 617-952-5299; Email: ddaneshvar@mgh.harvard.edu

Study Locations

• United States
  • Wisconsin
    • Mequon, Wisconsin, United States, 53097
      • Recruiting
      • Concordia University
      • Contact: Daniel H Daneshvar, MD, PhD

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

• at least 18 years of age
• health professions student (ex: Nursing, PT, OT, Pharmacy, Athletic Training) and/or a student-athlete at Concordia University (Ann Arbor or Mequon campus)

Exclusion Criteria:

- have previously viewed the TeachAids CrashCourse concussion education

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Other
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Active Comparator: 2D Concussion Education; During their in person study visit, participants will complete a brief ( ~5 minute) pre-survey before viewing the CrashCourse and Brain Fly-Through concussion educations. Participants in this group will receive both of these educations in 2D (via a video on a laptop). Participants will then be asked to complete a brief ( ~2 minute) survey to assess their knowledge, self-efficacy, and empathy surrounding concussions.	Other: CrashCourse Concussion Education in Virtual Reality; The TeachAids concussion education, including CrashCourse and Brain Fly-Through, will be shown in 3D (via a Virtual Reality headset). These educations are the exact same content as the 2D versions viewed on a laptop, but the modality (via a VR headset) is different.
Experimental: 3D Concussion Education; During their in person study visit, participants will complete a brief ( ~5 minute) pre-survey before viewing the CrashCourse and Brain Fly-Through concussion educations. Participants in this group will receive both of these educations in 3D (via a Virtual Reality headset). Participants will then be asked to complete a brief ( ~2 minute) survey to assess their knowledge, self-efficacy, and empathy surrounding concussions.	Other: CrashCourse Concussion Education in Virtual Reality; The TeachAids concussion education, including CrashCourse and Brain Fly-Through, will be shown in 3D (via a Virtual Reality headset). These educations are the exact same content as the 2D versions viewed on a laptop, but the modality (via a VR headset) is different.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change in the participant's knowledge, self-efficacy, and empathy surrounding concussions	Participants will take a pre-survey (prior to receiving the concussion education), an immediate post-survey (right after completion of the concussion education), and two-month post-survey (two months after the concussion education. These surveys will assess participant's knowledge, self-efficacy, and empathy surrounding concussions.	2 months

Collaborators and Investigators

• Sponsor: Piya Sorcar
• Collaborators: Massachusetts General Hospital; Concordia University Wisconsin
• Investigators: Principal Investigator: Daniel H Daneshvar, MD, PhD, TeachAids and Mass General Brigham

Study record dates

Study Major Dates

• Study Start (Actual): April 19, 2023
• Primary Completion (Estimated): July 31, 2024
• Study Completion (Estimated): July 31, 2024

Study Registration Dates

• First Submitted: April 19, 2023
• First Submitted That Met QC Criteria: April 19, 2023
• First Posted (Actual): May 1, 2023

Study Record Updates

• Last Update Posted (Actual): November 22, 2023
• Last Update Submitted That Met QC Criteria: November 20, 2023
• Last Verified: November 1, 2023

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Wounds and Injuries; Craniocerebral Trauma; Trauma, Nervous System; Head Injuries, Closed; Wounds, Nonpenetrating; Brain Injuries; Brain Injuries, Traumatic; Brain Concussion
• Other Study ID Numbers: 2D vs 3D - Concordia

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No